Third Harmonic Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-30.82	-35.16	-29.61	-12.81
Depreciation & Amortization	0.6	0.04	0	0
Share-Based Compensation	9.58	4.75	0.51	0.2
Other Operating Activities	0.22	-4.55	13.35	3.43
Operating Cash Flow	-20.43	-34.92	-15.75	-9.19
Capital Expenditures	-0.17	-0.04	0	0
Investing Cash Flow	-0.17	-0.04	0	0
Share Issuance / Repurchase	1.26	198.29	0	0
Other Financing Activities	-0.47	-2.29	135.75	10.83
Financing Cash Flow	0.8	195.99	135.75	10.83
Net Cash Flow	-19.8	161.04	120	1.64
Free Cash Flow	-20.59	-34.95	-15.75	-9.19
Free Cash Flow Per Share	-0.52	-2.44	-3.89	-1.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).